01 2Gowling Lafleur Henderson LLP
02 12Gowling WLG (Canada) LLP
03 1Blank
01 11218613
02 11336826
03 12149329
04 22340091
05 12350058
06 22350064
07 12372603
08 22378574
09 12635352
10 12771571
11 12783210
12 12904259
01 4RITUXIMAB
02 10Rituximab
03 1Blank
01 4SOLUTION
02 10Solution
03 1Blank
01 12004-03-03
02 12012-08-29
03 12013-11-12
04 12018-06-12
05 22019-08-11
06 32019-11-09
07 22020-05-04
08 22020-08-02
09 12026-11-14
10 12030-09-10
Patent Expiration Date : 2012-08-29
Date Granted : 1995-08-29
Brand Name : RITUXAN
Patent Number : 1336826
Filing Date : 1988-01-07
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-08-29
Date Granted : 1995-08-29
Patent Expiration Date : 2013-11-12
Date Granted : 2008-07-15
Brand Name : RITUXAN
Patent Number : 2149329
Filing Date : 1993-11-12
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2013-11-12
Date Granted : 2008-07-15
Patent Expiration Date : 2019-11-09
Date Granted : 2012-05-08
Brand Name : RITUXAN
Patent Number : 2350064
Filing Date : 1999-11-09
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-11-09
Date Granted : 2012-05-08
Patent Expiration Date : 2019-08-11
Date Granted : 2013-02-05
Brand Name : RITUXAN
Patent Number : 2340091
Filing Date : 1999-08-11
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-08-11
Date Granted : 2013-02-05
Patent Expiration Date : 2018-06-12
Date Granted : 2012-09-11
Brand Name : RITUXAN
Patent Number : 2635352
Filing Date : 1998-06-12
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2018-06-12
Date Granted : 2012-09-11
Patent Expiration Date : 2020-08-02
Date Granted : 2012-01-03
Brand Name : RITUXAN
Patent Number : 2378574
Filing Date : 2000-08-02
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-08-02
Date Granted : 2012-01-03
Patent Expiration Date : 2019-11-09
Date Granted : 2015-10-13
Brand Name : RITUXAN
Patent Number : 2350058
Filing Date : 1999-11-09
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-11-09
Date Granted : 2015-10-13
Patent Expiration Date : 2020-05-04
Date Granted : 2016-11-15
Brand Name : RITUXAN
Patent Number : 2904259
Filing Date : 2000-05-04
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-05-04
Date Granted : 2016-11-15
Patent Expiration Date : 2020-05-04
Date Granted : 2015-11-17
Brand Name : RITUXAN
Patent Number : 2372603
Filing Date : 2000-05-04
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-05-04
Date Granted : 2015-11-17
Patent Expiration Date : 2026-11-14
Date Granted : 2016-10-04
Brand Name : RITUXAN
Patent Number : 2783210
Filing Date : 2006-11-14
Strength per Unit : 10 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2026-11-14
Date Granted : 2016-10-04
LOOKING FOR A SUPPLIER?
Market Place
